News

Ideas That Generate Results

The therapeutic proteins market is estimated to have reached a value of around US$ 111 Billion in 2013, an increase of around 10% from the previous year. As the market matures towards effective commercialization of mAbs, insulins and coagulation factor products, there is a high scope of effective growth in future.
 
Improvements in drug delivery mechanisms, especially oral drug delivery methods, are also expected to boost the growth of these drugs. Drug delivery companies will see tremendous opportunities for expansion because of consistent rise in usage, and development and discovery of protein therapeutics. It is anticipated that the global protein therapeutics market may grow at a healthy CAGR of around 8% during the period 2013-2018 to reach US$ 165 Billion.
 
Our RNCOS research report, “Global Insulin Market Outlook 2018”, has revealed that the Insulin market has witnessed huge growth prospects based on these novel insulin delivery device systems. Recent advancements in administration of insulin include inhalable insulin, topical patches, spray insulin and painless insulin pens/pumps. Our comprehensive research work also studies how patent expiry of block buster insulin products would create opportunities for biosimilars.
 
The report conducts an in-depth analysis of diabetic patient population across leading geographies including India, China, US, Russia, etc. to understand the structure of the insulin market in these countries. The report covers insulin market break up by mode of action and synthesis. Our extensive study looks into the competitive landscape key players in the insulin market covering business overview, product portfolio, market share and company level activities. Overall, the research aims at presenting a balanced picture of the global insulin market to the clients.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM681.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm